Combination approach slows osteosarcoma growth and prolongs survival in preclinical models
Scientists co-led by St. Jude Children's Research Hospital have identified a potential therapeutic vulnerability in some forms of osteosarcoma.
Read original article on The Medical News →Related news
-
First-in-human study of dual-imaging catheter to assess heart attack risk, guide treatment
United Kingdom
-
CT scans reveal body composition changes preceding pancreatic cancer diagnosis
United Kingdom
-
Alzheimer’s biomarkers may help predict disease progression in ALS
United Kingdom
-
Paternal age may influence sex-specific gene expression changes in embryos
United Kingdom
-
An extra serving of fruit linked to lower risk of depression and anxiety in teenagers
United Kingdom
-
UC Davis Health introduces five-day accelerated treatment for severe depression
United Kingdom
-
Researchers identify new depression subtype linked to the body clock
United Kingdom
-
Study identifies potential treatment target for aggressive lung tumors
United Kingdom